1-4 of 4
Cassandra Hodgkinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A185: Combining unbiased network analysis and cancer genomics to guide precision medicine-oriented early-phase clinical trials

Pedro Torres-Ayuso, Sudhakar Sahoo, Christopher Chester, Cassandra Hodgkinson, Melanie Galvin, Hui Sun Leong, Kristopher Frese, Richard Marais, Caroline Dive, Matthew Krebs, John Brognard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A185.
https://doi.org/10.1158/1535-7163.TARG-17-A185
Published: 01 January 2018
View article titled, Abstract A185: Combining unbiased network analysis and cancer genomics to guide precision medicine-oriented early-phase clinical trials
Journal Articles

[18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941

Christopher Cawthorne, Natalie Burrows, Roben G. Gieling, Christopher J. Morrow, Duncan Forster, Jamil Gregory, Marc Radigois, Alison Smigova, Muhammad Babur, Kathryn Simpson, Cassandra Hodgkinson, Gavin Brown, Adam McMahon, Caroline Dive, Duncan Hiscock, Ian Wilson, Kaye J. Williams
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5): 819–828.
https://doi.org/10.1158/1535-7163.MCT-12-0905
Published: 08 May 2013
View article titled, [<sup>18</sup>F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941
Open the PDF for [<sup>18</sup>F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941 in another window
Includes: Supplementary data
Journal Articles

Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity

Jeffrey Cummings, Cassandra Hodgkinson, Rajesh Odedra, Patrizia Sini, Simon P. Heaton, Kirsten E. Mundt, Tim H. Ward, Robert W. Wilkinson, Jim Growcott, Andrew Hughes, Caroline Dive
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 455–463.
https://doi.org/10.1158/1535-7163.MCT-07-2136
Published: 17 March 2008
View article titled, Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
Open the PDF for Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity in another window
Journal Articles

An inducible caspase-3 “tumor death switch” model to identify circulating biomarkers of apoptotic cell death and test novel imaging probes for apoptosis.

Kathryn Taylor, Cassandra Hodgkinson, Martin Dawson, Lee Lancashire, Arek Welman, Christopher Cawthorne, Marion MacFarlane, Caroline Dive
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A49.
Published: 01 November 2007
View article titled, An inducible caspase-3 “tumor death switch” model to identify circulating biomarkers of apoptotic cell death and test novel imaging probes for apoptosis.